Home
June 2008 July 2008 August 2008
Su Mo Tu We Th Fr Sa
Week 27 1 2 3 4 5
Week 28 6 7 8 9 10 11 12
Week 29 13 14 15 16 17 18 19
Week 30 20 21 22 23 24 25 26
Week 31 27 28 29 30 31

Bladder Cancer Diagnosis & Monitoring Center - Media Resources Show Comments PDF Print E-mail
  
Bladder Cancer Diagnosis and Monitoring Center

Media Resources

Podcast - "Ask the Expert" - We Tried NMP22 Five Years Ago when it First Came Out and after Receiving False Negatives, We Elected to not Continue its Use. Do you have Confidence in the Sensitivity of the Test?
Thursday, 17 July 2008

Podcast - "Ask the Expert" - I am Getting a Positive NMP22 result but a Negative Cystoscopy. What does it Mean?
Thursday, 17 July 200

Podcast - "Ask the Expert" - Do You have an Opinion as to when the NMP22 Test Should be Run?
Thursday, 17 July 2008

Podcast - "Ask the Expert" - Should the NMP22 Test be Taken Prior to Cystoscopy or at the Same Patient Visit?
Thursday, 17 July 2008

Podcast - San Francisco Firefighters and Bladder Cancer Screening
Tuesday, 19 June 2007

Podcast - Updates on Bladder Cancer and San Francisco Firefighters
Tuesday, 19 June 2007

Podcast - AUA 2007 - Impact Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test
Tuesday, 22 May 2007

Podcast - AUA 2007 - Evaluation and Workup of Hematuria among Primary Care Physicians in Miami-Dade County: An Anonymous Questionnaire-based Survey
Tuesday, 22 May 2007

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay By Giora Katz, MD & Raoul Salup, MD and the NMP22 Clinical Investigation Group

Improving the Diagnosis of Bladder Cancer
By Mark S. Soloway MD - Combining Cystoscopy with a Physician's Office Tumor Marker Test - CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
By Barry Stein, MD, Giora Katz, MD and the NMP22 Clinical Investigation Group

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
By Yair Lotan MD

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
By Giora Katz, MD

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
By Giora Katz, MD

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
By H. Barton Grossman, M.D. and the NMP22 Clinical Investigation Group

Bladder Cancer Awareness Week
November 2006

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev